Limeng Zhang

机构：South China Agricultural University, Nanjing University of Chinese Medicine, Electric Power Research Institute, State Grid Corporation of China (China), Zhengzhou Normal University, Beike Biotechnology (China) · ORCID：0000-0002-8686-2300

发表论文 66 篇 · 总被引 1153 次 · h-index 18

代表论文

• The Role of Nrf2 in Relieving Cerebral Ischemia-Reperfusion Injury (2022 · Current Neuropharmacology · 被引 41)
• Rational design of pH-responsive nano-delivery system with improved biocompatibility and targeting ability from cellulose nanocrystals via surface polymerization for intracellular drug delivery (2024 · International Journal of Biological Macromolecules · 被引 29)
• EZH2 regulates pancreatic cancer cells through E2F1, GLI1, CDK3, and Mcm4 (2023 · Hereditas · 被引 16)
• The modulation effects of plant‐derived bioactive ingredients on chronic kidney disease: Focus on the gut–kidney axis (2023 · Food Frontiers · 被引 16)
• Gallic acid prevents obesity in mice on a high-fat diet via the gut microbiota-adipose tissue axis (2025 · Current Research in Food Science · 被引 15)
• Antimicrobial Peptides Relieve Transportation Stress in Ragdoll Cats by Regulating the Gut Microbiota (2023 · Metabolites · 被引 14)